Search

Your search keyword '"Litzow, Mark R"' showing total 533 results

Search Constraints

Start Over You searched for: Author "Litzow, Mark R" Remove constraint Author: "Litzow, Mark R" Publisher elsevier inc. Remove constraint Publisher: elsevier inc.
533 results on '"Litzow, Mark R"'

Search Results

1. DNTT-mediated DNA damage response drives inotuzumab ozogamicin resistance in B-cell acute lymphoblastic leukemia

2. Measurable residual disease and posttransplantation gilteritinib maintenance for patients with FLT3-ITD–mutated AML

3. A Multicenter Analysis of Allogeneic Transplant Outcomes in Adults with Philadelphia-Like B-Cell Acute Lymphoblastic Leukemia in First Complete Remission

4. Health-related quality of life with gilteritinib vs placebo posttransplant for FLT3-ITD+ acute myeloid leukemia

6. Epigenomic mapping reveals distinct B cell acute lymphoblastic leukemia chromatin architectures and regulators

8. DNA polymerase θ protects leukemia cells from metabolically induced DNA damage

13. Measurable residual disease does not preclude prolonged progression-free survival in CLL treated with ibrutinib

14. Degradation of Janus kinases in CRLF2-rearranged acute lymphoblastic leukemia

17. Molecular classification improves risk assessment in adult BCR-ABL1–negative B-ALL

19. Secondary cytogenetic abnormalities in core-binding factor AML harboring inv(16) vs t(8;21)

21. Bone marrow dendritic cell aggregates associate with systemic immune dysregulation in chronic myelomonocytic leukemia

22. A Personalized Prediction Model for Outcomes after Allogeneic Hematopoietic Cell Transplant in Patients with Myelodysplastic Syndromes

23. TGFβR-SMAD3 Signaling Induces Resistance to PARP Inhibitors in the Bone Marrow Microenvironment

25. Real-World Outcomes of Adult B-Cell Acute Lymphocytic Leukemia Patients Treated With Inotuzumab Ozogamicin

26. Real-world outcomes of adult B-cell acute lymphocytic leukemia patients treated with blinatumomab

27. Survival following allogeneic transplant in patients with myelofibrosis

31. Late effects after ablative allogeneic stem cell transplantation for adolescent and young adult acute myeloid leukemia

38. A pediatric regimen for older adolescents and young adults with acute lymphoblastic leukemia: results of CALGB 10403

39. Effect of Aging and Predonation Comorbidities on the Related Peripheral Blood Stem Cell Donor Experience: Report from the Related Donor Safety Study

40. Plerixafor alone for the mobilization and transplantation of HLA-matched sibling donor hematopoietic stem cells

41. Peripheral Blood versus Bone Marrow from Unrelated Donors: Bone Marrow Allografts Have Improved Long-Term Overall and Graft-versus-Host Disease-Free, Relapse-Free Survival

42. Comparative Analysis of Calcineurin Inhibitor–Based Methotrexate and Mycophenolate Mofetil–Containing Regimens for Prevention of Graft-versus-Host Disease after Reduced-Intensity Conditioning Allogeneic Transplantation

44. Myeloablative vs reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chronic myeloid leukemia

45. Mayo Alliance Prognostic Model for Myelodysplastic Syndromes: Integration of Genetic and Clinical Information

46. Extracorporeal Photopheresis Improves Survival in Hematopoietic Cell Transplant Patients with Bronchiolitis Obliterans Syndrome without Significantly Impacting Measured Pulmonary Functions

47. Hypomethylating agents in relapsed and refractory AML: outcomes and their predictors in a large international patient cohort

50. Allogeneic Hematopoietic Cell Transplantation for Adult Chronic Myelomonocytic Leukemia

Catalog

Books, media, physical & digital resources